Exposure to TNF inhibitors is rare at MOGAD presentation-Reference-Cited by-同舟云学术

Exposure to TNF inhibitors is rare at MOGAD presentation

Published:2022-01 Issue: Volume:432 Page:120044
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Redenbaugh Vyanka,Flanagan Eoin P.,Floris Valentina,Zara Pietro,Bhatti M. Tariq,Sanchez Francisco,Koster Matthew,Mariotto Sara,Pittock Sean J.,Chen John J.,Cauli Alberto,Solla Paolo,Sechi Elia

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference12 articles.

1. NMOSD with anti-MOG antibodies following anti-TNFα therapy: a case report;Lommers;Mult. Scler. Relat. Disord.,2018

2. Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events;Kunchok;JAMA Neurol.,2020

3. CNS demyelination with TNFα inhibitor exposure: a retrospective cohort study;Hutto;J. Neuroimmunol.,2021

4. Demyelinating events following initiation of anti-TNFα therapy in the British society for rheumatology biologics registry in rheumatoid arthritis;Taylor;Neurol. Neuroimmunol. Neuroinflamm.,2021

5. Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing;Sechi;JAMA Neurol.,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MOG antibody-associated optic neuritis;Eye;2024-05-23

2. Delimiting MOGAD as a disease entity using translational imaging;Frontiers in Neurology;2023-12-07

3. NF-κB and STAT3 activation in CD4 T cells in pediatric MOG antibody-associated disease;Journal of Neuroimmunology;2023-11

4. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease;Frontiers in Neurology;2023-02-28

5. The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway;Journal of Neuro-Ophthalmology;2022-12-08